BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gountas I, Sypsa V, Papatheodoridis G, Souliotis K, Athanasakis K, Razavi H, Hatzakis A. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals. World J Gastroenterol 2019; 25(11): 1327-1340 [PMID: 30918426 DOI: 10.3748/wjg.v25.i11.1327] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Trickey A, Hiebert L, Perfect C, Thomas C, El Kaim JL, Vickerman P, Schȕtte C, Hecht R. Hepatitis C virus elimination in Indonesia: Epidemiological, cost and cost-effectiveness modelling to advance advocacy and strategic planning. Liver Int 2020;40:286-97. [PMID: 31454466 DOI: 10.1111/liv.14232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Roux P, Donadille C, Magen C, Schatz E, Stranz R, Curado A, Tsiakou T, Verdes L, Aleksova A, Carrieri P, Mezaache S, Charif Ali B; Eurosider study group. Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study. Int J Drug Policy 2021;87:102992. [PMID: 33096364 DOI: 10.1016/j.drugpo.2020.102992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Crespo J, Albillos A, Buti M, Calleja JL, García-Samaniego J, Hernández-Guerra M, Serrano T, Turnes J, Acín E, Berenguer J, Berenguer M, Colom J, Fernández I, Fernández Rodríguez C, Forns X, García F, Rafael Granados, Lazarus JV, Molero JM, Molina E, Pérez Escanilla F, Pineda JA, Rodríguez M, Romero M, Roncero C, Saiz de la Hoya P, Sánchez Antolín G. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH). Gastroenterol Hepatol 2019;42:579-92. [PMID: 31594683 DOI: 10.1016/j.gastrohep.2019.09.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
4 Gountas I, Hatzakis A, Nikolopoulos G, Touloumi G, Souliotis K. The cost of a late-detected outbreak among people who inject drugs. A modeling study. Int J Drug Policy 2021;88:103032. [PMID: 33212371 DOI: 10.1016/j.drugpo.2020.103032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Gountas I, Yiasemi I, Kyprianou E, Mina C, Georgiou C, Katsioloudes P, Kouroufexi A, Demetriou A, Xenofontos E, Nikolopoulos G. Planning the hepatitis C virus elimination in Cyprus: A modeling study. World J Gastroenterol 2021; 27(31): 5219-5231 [PMID: 34497446 DOI: 10.3748/wjg.v27.i31.5219] [Reference Citation Analysis]
6 Crespo J, Albillos A, Buti M, Calleja JL, Garcia-samaniego J, Hernández-guerra M, Serrano T, Turnes J, Acín E, Berenguer J, Berenguer M, Colom J, Fernández I, Fernández Rodríguez C, Forns X, García F, Granados R, Lazarus J, Molero JM, Molina E, Pérez Escanilla F, Pineda JA, Rodríguez M, Romero M, Roncero C, Saiz de la Hoya P, Sánchez Antolín G. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH). Gastroenterología y Hepatología (English Edition) 2019;42:579-92. [DOI: 10.1016/j.gastre.2019.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Kouroumalis E, Voumvouraki A. Hepatitis C virus: A critical approach to who really needs treatment. World J Hepatol 2022; 14(1): 1-44 [DOI: 10.4254/wjh.v14.i1.1] [Reference Citation Analysis]
8 Xiong X, Ni T. Analyzing the Influencing Factors of Economic Fluctuations in the Era of Big Data. Scientific Programming 2022;2022:1-10. [DOI: 10.1155/2022/9374025] [Reference Citation Analysis]
9 Crespo J, Cuadrado A, Perelló C, Cabezas J, Llerena S, Llorca J, Cedillo S, Llop E, Escudero MD, Hernández Conde M, Puchades L, Redondo C, Fortea JI, Gil de Miguel A, Serra MA, Lazarus JV, Calleja JL. Epidemiology of hepatitis C virus infection in a country with universal access to direct-acting antiviral agents: Data for designing a cost-effective elimination policy in Spain. J Viral Hepat 2020;27:360-70. [PMID: 31755634 DOI: 10.1111/jvh.13238] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
10 Nakitanda AO, Duffell E. Hospital discharges of hepatocellular carcinoma and non-alcohol related cirrhosis in the EU/EEA and United Kingdom: a descriptive analysis of 2004-2015 data. Infect Dis (Lond) 2020;52:816-27. [PMID: 32838640 DOI: 10.1080/23744235.2020.1799068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]